![]() |
市場調查報告書
商品編碼
1828115
2025年全球內視鏡治療設備市場報告Endotherapy Devices Global Market Report 2025 |
近年來,內視鏡治療設備市場規模強勁成長,從2024年的46.3億美元增至2025年的48.7億美元,複合年成長率為5.2%。預測期內的成長可歸因於胃腸道疾病盛行率的上升、人口老化、認知度的提高和早期診斷、有利的報銷政策、全球經濟發展以及策略聯盟和夥伴關係。
預計未來幾年內視鏡治療設備市場規模將強勁成長,到2029年將達到65.7億美元,複合年成長率為7.8%。預測期內的成長可歸因於微創技術的進步、慢性病負擔的增加、醫療基礎設施的擴展、對早期檢測的重視程度的提高、監管支持和標準化。預測期內的全球趨勢包括影像技術的進步、人工智慧的整合、技術進步、醫療基礎設施的全球擴張以及胃腸道疾病盛行率的上升。
內視鏡設備是用於內視鏡檢查的醫療器械,旨在診斷、治療和管理各種醫療領域的各種疾病,包括胃腸道、大腸鏡、腹腔鏡、關節鏡、關節鏡和支氣管鏡。這些醫療設備專門設計用於與內視鏡配合使用。內視鏡是一種配有光源和攝影機的軟性導管,可幫助醫生更有效地直覺地檢查內臟器官。
內視鏡器械的主要類別包括胃腸器械及配件、內視鏡逆行性造影器材及配件及其他內視鏡器械。胃腸器械及配件是用於診斷和治療胃腸道 (GI) 疾病的醫療工具。它們在各種手術中發揮重要作用,例如內視鏡檢查,它可以觀察消化道內部,包括食道、胃、十二指腸和大腸。此外,這些器械也用於外科手術,直接向患處提供標靶治療。這些器械廣泛應用於神經科學用內視鏡、關節鏡、腹腔鏡檢查、泌尿系統檢查、神經內視鏡檢查、胃腸內視鏡檢查以及醫院、門診手術中心和其他最終用戶執行的其他醫療程序。
2025年春季美國關稅突然上調及其引發的貿易摩擦,對醫療設備領域產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰進一步加劇了形勢,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供內視鏡治療設備的市場統計數據,包括全球市場規模、區域佔有率、市場佔有率競爭對手、詳細的內視鏡治療設備細分市場、市場趨勢和商業機會,以及您在內視鏡治療設備行業取得成功所需的數據。本內視鏡治療設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年7.8%的預測成長率比我們先前對該市場的預測略有下降,下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會透過對來自法國和荷蘭等主要地區的止血夾和內視鏡縫合系統徵收關稅直接影響美國,這可能導致治療性介入延遲並增加胃腸道消化道出血的治療成本。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響,這種影響也將更加廣泛。
預計未來胃腸道疾病發病率的上升將推動治療性內視鏡市場的成長。消化系統疾病會影響從口腔到肛門的消化道,包括大腸直腸癌、胃食道逆流、潰瘍性大腸炎(UC)、發炎性腸道疾病 (IBD) 和克隆氏症(CD) 等疾病。內視鏡檢查透過非侵入性或微創手術來治療和診斷胃腸道疾病,解決潰瘍、出血、乳糜瀉、阻塞、發炎和消化道腫瘤等問題。內視鏡檢查也有助於找出胃灼熱、腹痛、噁心、嘔吐和出血等不明原因症狀的原因。例如,根據澳洲癌症協會 (Cancer Australia) 的報告,預計 2023 年澳洲將新增 2,576 例胃癌病例,其中包括 1,647 名男性和 929 名女性。 85歲前確診胃腸道疾病的風險約為1/117(0.85%),其中男性為1/91(1.1%),女性為1/164(0.61%)。因此,胃腸道疾病的盛行率不斷上升,推動了內視鏡設備市場的成長。
肥胖症盛行率的上升進一步推動了內視鏡設備市場的成長。肥胖症的特徵是體內多餘脂肪的堆積,會對健康產生負面影響,而內視鏡設備可以有效控制肥胖。這些設備在減重、減少食慾、改善生活品質、提供微創治療以及為肥胖管理提供臨時干預措施方面發揮著重要作用。根據世界肥胖組織預測,2025年,肥胖人數將增加至8.92億,2030年將達到10.25億人。在英國,預計2021年至2022年間,18歲以上族群中25.9%將肥胖。因此,肥胖症的流行是推動內視鏡設備市場擴張的主要因素。
內視鏡設備市場的主要企業正在開發創新解決方案,例如紅二向色成像 (RDI),以提高內視鏡檢查過程中血管和出血部位的可視化效果。 RDI 利用兩種不同波長的光來增強血管和病變的可見性,從而提高檢查過程中的診斷準確性。例如,總部位於日本的醫療科技公司奧林巴斯株式會社於 2023 年 10 月推出了 EVIS X1 內視鏡系統。這款尖端系統將先進的成像技術與人工智慧相結合,以提高視覺化和診斷能力。 EVIS X1 具有紋理和色彩增強成像 (TXI) 功能,可透過增強色彩和紋理來增強病灶和息肉的可見性。此外,RDI 專注於深層血管和出血部位,而亮度可調且對比度保持的成像 (BAI-MAC) 可確保整個影像的亮度水平均衡。
內視鏡治療設備市場的主要企業正策略性地專注於內視鏡系統等創新產品,以推動市場收益。內視鏡系統是用於內部器官檢查的微創醫療技術。例如,日本光學儀器和影印機製造商奧林巴斯公司於 2023 年 10 月推出了 EVIS X1。該系統配備了紅色雙色成像 (RDI™) 和紋理和色彩增強成像 (TXIT™) 等尖端成像技術,可增強胃腸道的可視性並識別異常。符合人體工學的握把控制裝置重量減輕 10%,操作舒適。 EVIS X1 內視鏡系統的推出體現了奧林巴斯致力於推進內視鏡技術並向醫療專業人員提供高品質治療所需工具的承諾。
2024年1月,日本醫療科技公司奧林巴斯株式會社收購了泰熊醫療株式會社。此次收購使奧林巴斯能夠透過提供廣泛的臨床差異化技術,改善患者治療效果並提升胃腸道護理水平。泰熊醫療株式會社是一家韓國製造商,專門生產包括胃腸道 (GI) 金屬支架在內的醫療設備。
內視鏡治療設備市場的主要企業包括奧林巴斯公司、波士頓科學公司、康美德公司、美敦力公司、富士膠片控股公司、強生庫克集團公司、Karl Storz SE & Co. KG、史賽克公司、泰熊醫療有限公司、全錄輝公司、Steris 公司、微技術(南京)有限公司、豪雅公司、庫克Group Limited、B. Healthcare、賓得醫療、尼普洛公司、MEDIVATORS BV、美國內視鏡集團公司、理查德·沃爾夫有限公司、Cantel Medical Corp.、富士能公司、Gyrus ACMI、Cogentix Medical Inc. 和 Endogastric Solutions Inc.。
2024年,北美將成為內視鏡治療設備市場最大的地區。預計亞太地區將成為預測期內全球內視鏡治療設備市場成長最快的地區。內視鏡治療設備市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
內視鏡治療設備市場報告涵蓋的國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙
內視鏡治療設備市場涵蓋機械增強大腸鏡、內視鏡止血設備、組織取樣設備、金屬支架、擴張球囊、異物取出設備、電外科手術設備以及UCR充氣設備等設備的銷售。該市場的價值為“出廠價”,即商品製造商或生產商向其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。
Endotherapy devices are medical instruments employed in endoscopic procedures aimed at diagnosing, treating, and managing various disorders across different medical fields such as gastrointestinal, colonoscopy, laparoscopy, anoscopy, arthroscopy, bronchoscopy, and others. These devices are specifically designed for use in conjunction with an endoscope, a flexible tube equipped with a light and camera that enables physicians to visually inspect the internal organs more effectively.
The primary categories of endotherapy devices include gastrointestinal devices and accessories, endoscopic retrograde cholangiopancreatography devices and accessories, and other endotherapy devices. Gastrointestinal devices and accessories are medical tools utilized in the diagnosis and treatment of gastrointestinal (GI) disorders. They play a crucial role in various procedures, including endoscopic examinations that allow visualization and access to the inside of the GI tract, covering areas such as the esophagus, stomach, duodenum, and colon. Additionally, these devices are employed in surgical interventions to deliver targeted therapies directly to affected areas. These devices find extensive applications in bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and other medical procedures performed by hospitals, ambulatory surgical centers, and other end-users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The endotherapy devices market research report is one of a series of new reports from The Business Research Company that provides endotherapy devices market statistics, including endotherapy devices industry global market size, regional shares, competitors with an endotherapy devices market share, detailed endotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the endotherapy devices industry. This endotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endotherapy devices market size has grown strongly in recent years. It will grow from $4.63 billion in 2024 to $4.87 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to the rising prevalence of gastrointestinal disorders, the aging population, increased awareness and early diagnosis, favorable reimbursement policies, global economic development, strategic collaborations and partnerships.
The endotherapy devices market size is expected to see strong growth in the next few years. It will grow to $6.57 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to advancements in minimally invasive techniques, the growing burden of chronic diseases, expansion of healthcare infrastructure, increased focus on early detection, regulatory support and standardization. Major trends in the forecast period include advances in imaging technologies, integration of artificial intelligence, technological advancements, global expansion of healthcare infrastructure, and increased prevalence of gastrointestinal disorders.
The forecast of 7.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on hemostasis clips and endoscopic suturing systems, sourced from key regions such as France and the Netherlands, which could lead to delayed therapeutic interventions and higher costs for gastrointestinal bleeding management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of gastrointestinal diseases is projected to drive the growth of the endotherapy devices market in the future. Gastrointestinal illnesses affect the digestive tract from the mouth to the anus and include conditions such as colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), and Crohn's disease (CD). Endotherapy devices are employed in the treatment and diagnosis of gastrointestinal diseases through non-invasive or minimally invasive surgical procedures, addressing issues like ulcers, bleeding, celiac disease, obstructions, inflammation, and tumors within the gastrointestinal tract. They also assist in identifying the source of unexplained symptoms such as heartburn, abdominal pain, nausea, vomiting, and bleeding. For instance, reports from Cancer Australia, an Australian organization, indicate that in 2023, Australia is expected to see 2,576 new cases of stomach cancer, comprising 1,647 in males and 929 in females. The lifetime risk of diagnosis by age 85 is approximately 1 in 117 (0.85%), with males facing a risk of 1 in 91 (1.1%) and females 1 in 164 (0.61%). Therefore, the rising incidence of gastrointestinal diseases is driving growth in the endotherapy devices market.
The growth of the endotherapy devices market is further fueled by the rising prevalence of obesity. Obesity, characterized by the excessive accumulation of body fat with adverse effects on health, can be effectively managed with endotherapy devices. These devices play a crucial role in weight loss, appetite reduction, improving the quality of life, providing minimally invasive treatment, and offering temporary interventions for obesity management. According to World Obesity, the number of obese individuals is expected to increase to 892 million in 2025 and reach 1,025 million in 2030. In England, it was projected that 25.9% of individuals aged 18 and older were obese in 2021-2022. Consequently, the growing prevalence of obesity is a key driver for the expansion of the endotherapy devices market.
Key companies in the endotherapy devices market are developing innovative solutions, such as red dichromatic imaging (RDI), to improve the visualization of blood vessels and bleeding sites during endoscopic procedures. RDI enhances the visibility of blood vessels and lesions by utilizing two different wavelengths of light, which improves diagnostic accuracy during procedures. For example, in October 2023, Olympus Corporation, a medical technology company based in Japan, launched the EVIS X1 endoscopy system. This cutting-edge system integrates advanced imaging technologies and artificial intelligence to enhance visualization and diagnostic capabilities. The EVIS X1 features texture and color enhancement imaging (TXI), which improves the visibility of lesions and polyps by enhancing their color and texture. Additionally, RDI focuses on deep blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) ensures balanced brightness levels throughout the image.
Major companies in the endotherapy devices market are strategically focusing on innovative products such as endoscopy systems to drive market revenues. An endoscopy system is a minimally invasive medical technology used for internal organ examination. For example, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, launched EVIS X1 in October 2023. Equipped with cutting-edge imaging technologies such as red dichromatic imaging (RDITM) and texture and color enhancement imaging (TXITM), the system enhances visibility and abnormality identification in the gastrointestinal tract. Notable features include a 10% lighter ErgoGrip control section for improved user comfort and scope handling. The introduction of the EVIS X1 endoscopic system reflects Olympus' commitment to advancing endoscopy technology and providing medical professionals with the tools necessary for high-quality treatment.
In January 2024, Olympus Corporation, a medical technology company based in Japan, acquired Taewoong Medical Co. Ltd. for an undisclosed sum. This acquisition allows Olympus to improve patient outcomes by providing a wider range of clinically differentiated technologies, thereby elevating the standard of care in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a manufacturer located in South Korea that specializes in medical devices, including gastrointestinal (GI) metallic stents.
Major companies operating in the endotherapy devices market include Olympus Corporation, Boston Scientific Corporation, Conmed Corporation, Medtronic Plc, Fujifilm Holdings Corporation, Johnson & JohnsonCook Group Incorporated, Karl Storz SE & Co. KG, Stryker Corporation, Taewoong Medical Co. Ltd, Smith & Nephew Plc., Steris Corporation, Micro-Tech (Nanjing) Co Ltd., HOYA Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Frontier Healthcare, Pentax Medical, Nipro Corporation, MEDIVATORS B.V., US Endoscopy Group Inc., Richard Wolf GmbH, Cantel Medical Corp., Fujinon Corporation, Gyrus ACMI, Cogentix Medical Inc., Endogastric Solutions Inc.
North America as the largest region in the endotherapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the endotherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The endotherapy devices market consists of sales of devices such as mechanically enhanced colonoscopies, endoscopic hemostasis, tissue sampling devices, metallic stents, dilation balloons, foreign body retrieval devices, electrosurgical needs, and UCR insufflators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endotherapy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on endotherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for endotherapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endotherapy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.